Pricing Log in Create free account

Oric Pharmaceuticals, Inc. (ORIC) vs Savara Inc. (SVRA)

Oric Pharmaceuticals, Inc. and Savara Inc. are both Biotechnology companies. Oric Pharmaceuticals, Inc. and Savara Inc. are of similar size ($899.9M and $880.0M). Across the 10 metrics below, Oric Pharmaceuticals, Inc. leads on 7 and Savara Inc. on 3.

Valuation

Metric ORIC SVRA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.49 8.53 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (15.34%) (12.01%) (32.88%)
Free cash flow yield (11.81%) (9.04%) (23.13%)

Profitability

Metric ORIC SVRA Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (39.80%) (105.48%) (51.96%)
Return on assets (37.35%) (78.28%) (46.06%)
Return on invested capital (83.77%) (12,213.18%) 0.00%

Growth

Metric ORIC SVRA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 19.67% (10.42%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ORIC SVRA Biotechnology median
Debt to equity 0.00 0.21 0.00
Current ratio 13.19 10.13 4.97
Net debt to EBITDA 1.95 1.64 1.01

Dividend

Metric ORIC SVRA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ORIC SVRA Biotechnology median
Market cap 880.01m 899.91m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack